EIDOS THERAPEUTICS, INC.

EIDX NASDAQ
40.75
+0.52
+1.29%
盘后: 40.75 0 0.00% 17:04 07/16 EDT
开盘
40.23
昨收
40.23
最高
40.75
最低
39.88
成交量
15.61万
成交均量(3M)
16.45万
52周最高
40.75
52周最低
8.89
换手率
0.44%
市值
14.59亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供EIDOS THERAPEUTICS, INC. EIDX股票价格,EIDOS THERAPEUTICS, INC.股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Eidos Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on addressing the unmet need in diseases caused by transthyretin (TTR), amyloidosis (ATTR). It focuses on treating the disease by targeting them at their collective source by stabilizing TTR. The Company’s product candidate, AG10, is an orally-administered small molecule designed to potently stabilize tetrameric TTR, thereby halting at its outset the series of molecular events that give rise to ATTR. AG10 binds and stabilizes TTR in the blood, preventing the formation of amyloid and halting progression of the disease.
展开 >

最近浏览

名称
价格
涨跌幅